 intens chemotherapi induct interferon-alpha mainten patient philadelphia chromosome-posit chronic myelogen leukemia pilot studi patient philadelphia chromosome-posit chronic myelogen leukemia intens chemotherapi induct interferon-alpha ifn-a mainten intens chemotherapi cycl daunorubicin day cytarabin day mg day mg day doap mainten therapi ifn-a dose daili count toxic outcom patient match histor popul patient ifn-a overal patient cytogenet respons partial complet induct chemotherapi cytogenet respons ifn-a mainten median follow-up month surviv rate patient match histor group incid lymphoid blastic transform group durabl cytogenet respons summari addit intens chemotherapi induct ifn-a mainten surviv rate incid lymphoid blastic transform incid durabl cytogenet respons result ifn-a therapi